Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This research study will look at the effects (good or bad) of administering cyclophosphamide,
fludarabine, and rituximab. Clinical studies with combination therapy have shown higher
response rates than using single drugs, and this study will evaluate the side effects and
effectiveness of this combination.